Reserpine, gastric secretion, and peptic ulcer
- 25 Downloads
Summary and conclusions
1. Single, orally administered doses (0.25 mg. to 0.5 mg.) of reserpine such as are used in the management of hypertension, stimulate HCl secretion only mildly; this effect is prevented by simultaneous administration of a therapeutic dose of an anticholinergic drug. Prolonged therapy with reserpine in these doses does not lead to gastric hypersecretion.
2. Single large doses of reserpine (1 mg. or more) given orally or parenterally usually provoke an intense and sustained secretion of acid, not prevented by even large doses of anticholinergics. The cumulative effects of these large doses is unknown.
3. The evidence to date does not establish reserpine as an important ulcerogenic agent.
KeywordsPublic Health Hypertension Peptic Ulcer Large Dose Cumulative Effect
Unable to display preview. Download preview PDF.
- 1.Barrett, W. E.,et al. Effect of reserpine on gastric secretion of the dog.J. Pharmacol. & Exper. Therap. 113:3, 1955.Google Scholar
- 2.Barrett, W. E., Ruthedge, R. A., andRogie, B. Action of Serpasil on gastrointestinal motility and secretion.Proc. Soc. Exper. Biol. & Med. 13:334, 1954.Google Scholar
- 3.Beman, F. M., Knoll, H. C., andDelor, C. J. The effect of reserpine on gastric secretion.Clin. Res. Proc. 3:131, 1955.Google Scholar
- 4.Bom, F., Friderichsen, T., andJensen, A. R. Autonomic action of reserpine (Serpasil) especially toward vago-insulin system.Ugesk. laeger 118:329, 1956.Google Scholar
- 6.Cummins, J. F., andBalfour, D. C., Jr. Effect of Rauwolfia alkaloids on the excretion of uropepsin in the human.J.A.M.A. 161:864, 1956.Google Scholar
- 9.Drenick, E. J. Reserpine in peptic ulcer.Am. J. Digest. Dis. N.S. 1:521, 1956.Google Scholar
- 10.Egdahl, R. H., Richards, J. B., andHume, D. M. Effect of reserpine on adrenocortical function in unanesthetized dogs.Science 123:418, 1956.Google Scholar
- 13.Hollister, L. E. Hematemesis and melena complicating therapy with rauwolfia alkaloids.Arch. Int. Med. 99:218, 1957.Google Scholar
- 14.Hollister, L. E. Complications from the use of tranquilizing drugs.New England J. Med. 257:170, 1957.Google Scholar
- 15.Hollister, L. E.,et al. Treatment of chronic schizophrenic reactions with reserpine.Ann. New York Acad. Sci. 61:92, 1955.Google Scholar
- 17.Kirsner, J. B., andFord, H. Effect of reserpine upon basal gastric secretion.Arch. Int. Med. 99:390, 1957.Google Scholar
- 18.Liebowitz, D., andCarbone, J. V. Effect of varying doses of reserpine on gastric secretion.New England J. Med. 257:227, 1957.Google Scholar
- 19.Plummer, A. J.,et al. Pharmacology of rauwolfia alkaloids, including reserpine.Ann. New York Acad. Sc. 59:8, 1954.Google Scholar
- 20.Rider, J. A. Effect of prolonged oral administration of reserpine (Reserpoid) on gastric secretion.Proc. Soc. Exper. Biol. & Med. 90:636, 1955.Google Scholar
- 21.Schneider, E. M., andClark, M. L. Hyperchlorhydria induced by intravenous reserpine: Response to various therapeutic agents.Am. J. Digest. Dis. N.S. 1:22, 1956.Google Scholar
- 22.Schroeder, H. A., andPerry, H. M. Psychosis apparently produced by reserpine.J.A.M.A. 159:839, 1955.Google Scholar
- 23.Shay, H., Sun, D. C. H., andGruenstein, M. Effect of serotonin and reserpine on interdigestive gastric secretion in the rat.Fed. Proc. 16(1):118, 1957.Google Scholar
- 24.Ubillus, R. Effects of reserpine on the digestive tract. Reported in “Foreign Letters,”J.A.M.A. 162:1074, 1956.Google Scholar
- 25.Wolf, J., andRossman, M. E. Effects of reserpine on gastric secretion.Am. J. Gastroenterol. 25:430, 1956.Google Scholar
- 26.Wofford, J. D., andCummins, A. J. Hemorrhage from duodenal ulcer during the administration of reserpine.New England J. Med. 255:1193, 1956.Google Scholar
- 29.Kert, M. Personal communication.Google Scholar